Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract

British Medical Journal

Volumn 333, Issue 7582, 2006, Pages 1293-1294

  Finall, A I ^a   McIntosh, S A ^b   Thompson, W D ^b  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; VISCUM ALBUM EXTRACT;

ADJUVANT THERAPY; ADULT; ANAMNESIS; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INJECTION SITE INFLAMMATION; METASTASIS; MICROSCOPY; MULTIPLE CYCLE TREATMENT; MUSCLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; SKIN INFLAMMATION; VISCUM ALBUM;

BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; MISTLETOE; PHYTOTHERAPY; PLANT EXTRACTS; SKIN NEOPLASMS;

EID: 33845943959     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39044.460023.BE     Document Type: Article

References (14)

1. Harris RB, Duncan SC, Ecker RI, Winkleman RK. Lymphoid follicles in subcutaneous inflammatory disease. Arch Dermatopathol 1999;21:365-8.
2. Peters MS, Su WPD. Eosinophils in lupus panniculitis and morphea profunda. J Cutan Pathol 1991;18:189-92.
3. Janis JF, Winkleman RK. Histopathology of the skin in dermatomyositis. Arch Dermatol 1968;97:640-50.
4. Winkleman RK, Barker SM. Factitial traumatic panniculitis. J Am Acad Dermatol 1985;13:988-94.
5. Jaffe N, Hann HWL, Vawter GF. Post-steroid panniculitis in acute leukaemia. N Engl J Med 1971;284:366-7.
6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
7. Kaegi E. Unconventional therapies for cancer: 3. Iscador. CMAJ 1998;158:1157-9.
8. National Cancer Institute. Mistletoe extracts. www.cancer.gov/cancerinfo/ pdq/cam/mistletoe.
9. Porter R. The greatest benefit to mankind. In: A medical history of humanity from antiquity to the present. London: Harper Collins, 1997:112.
10. Ernst E, Schmit K, Steuer-Vogt MK. Mistletoe for cancer? A systematic review of randomised controlled trials. Int J Cancer 2003;107:262-7.
11. Kienle GS, Berrino F, Bussing A, Portalupi E, Rosenzweig S, Kiene H. Mistletoe in cancer-a systematic, review on controlled clinical trials. Eur J Med Res 2003;8:109-19.
12. Mabed M, El-Helw L, Shamaa S. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma. Br J Cancer 2004;90:65-9.
13. Huber R, Barth H, Schmitt-Graf A, Klein R. Hypereosinophilia induced by high-dose intra-tumoral and peri-tumoral mistletoe application 10 a patient with pancreatic carcinoma. J Altern Complement Med 2000;16:305-10.
14. Gorter RW, van Wiley M, Stoss M, Wollina U. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador). Am J Health Ther 1998;5:181-7.